TIDMUBI

RNS Number : 8064F

Ubisense Group PLC

29 April 2014

29 April 2014

Ubisense Group plc

("Ubisense" or the "Company")

Additional Listing

The Company announces that an application has been made to the London Stock Exchange for admission to trading on AIM ("Admission") of 750,000 Ordinary Shares of 2p each in the Company ("Ordinary Shares") under the Company's existing blocklisting scheme. These Ordinary Shares will be available to satisfy future exercises of options over Ordinary Shares under the rules of the Company's employee share option schemes. It is expected that these Ordinary Shares will rank pari passu with the existing Ordinary shares and that Admission will become effective on 6 May 2014.

About Ubisense

Ubisense is a market leader in real time location intelligence solutions which enable companies to optimise their business processes. By keeping track of key assets, Ubisense solutions bring clarity to complex operations whilst also improving quality and reliability. Ubisense Real-Time Location Intelligence Solutions are used by a number of blue chip customers across the world, such as AGCO, Airbus, Aston Martin, BMW, Cablevision, Daimler, Deutsche Telekom, Duke Energy, John Deere, MINI and VW.

Ubisense is headquartered in Cambridge, UK, with offices in the USA; Canada; France; Germany; Japan; Korea; Philippines and Singapore. For more information visit: http://www.ubisense.net

 
Contact: 
 
Ubisense Group                     Tel: +44 (0) 1223 535170 
Richard Green 
Robert Parker 
 
Canaccord Genuity Limited (NOMAD)  Tel: +44 (0) 20 7523 8000 
Simon Bridges 
Lucy Tilley 
 
FTI Consulting                     Tel: +44 (0) 20 7831 3113 
Jon Snowball 
 Tracey Bowditch 
 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

LISBSGDSLXDBGSC

Ubisense (LSE:UBI)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024 Click aqui para mais gráficos Ubisense.
Ubisense (LSE:UBI)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024 Click aqui para mais gráficos Ubisense.